Johnson and Johnson (France) Company Profile

13:08 EDT 29th March 2017 | BioPortfolio

Our pharmaceuticals companies offer medicines that treat many of the world's most serious and widespread diseases. These diseases range from cancer, HIV/AIDS and bacterial infections to schizophrenia, epilepsy, rheumatoid arthritis and psoriasis. In 2007, we invested $5.3 billion in the search for new ways to treat these diseases and many others. It’s all part of our commitment to helping you and the ones you love lead longer, healthier lives.

These companies are organized into three global business units:

Central Nervous System and Internal Medicine

This business unit develops medicines for an array of health problems, including central nervous system disorders, such as schizophrenia and epilepsy; metabolic diseases, such as diabetes; cardiovascular diseases; and infectious diseases.

B.I.O. (Biotechnology, Immunology & Oncology)

This business unit develops traditional and biologic medicines to treat autoimmune disorders, such as rheumatoid arthritis, psoriasis, and Crohn’s disease; a wide range of cancers; and blood disorders, such as anemia.


This business unit develops medicines for the treatment of infectious diseases, such as HIV/AIDS, hepatitis C and tuberculosis.


rue camille desmoulins
issy les moulineaux cedex 9


Phone: 33-155004174

News Articles [1860 Associated News Articles listed on BioPortfolio]

ROUNDUP 2: Johnson & Johnson klopft bei Biotech-Unternehmen Actelion an

(neu: Stellungnahme von Johnson & Johnson, Kurs nach Börsenschluss, Händlereinschätzung) NEW BRUNSWICK/BASEL (dpa-AFX) - Der US-amerikanische Pharma- und Konsumgüterriese Johnson & Johnson (J&J) w...

Johnson & Johnson cautious in outlook, shops diabetes care

In this July 16, 2012, file photo, Johnson & Johnson products are displayed in Orlando, Fla. On Tuesday, Jan. 24, 2017, Johnson & Johnson reports financial results.

Johnson & Johnson Ends Takeover Discussions with Actelion Pharmaceuticals

NEW BRUNSWICK, N.J., Dec. 13, 2016 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today confirmed it has ended discussions with Actelion Pharmaceuticals Ltd. (SIX: ATLN) regarding a potential ...

Johnson & Johnson and Actelion end discussion about strategic transaction

Johnson & Johnson confirmed it has ended discussions with Actelion Pharmaceuticals Ltd. regarding a potential transaction. Johnson & Johnson was not able to reach an agreement that it believed would...

Johnson & Johnson hit with over $1b verdict on hip implants

The logo of healthcare company Johnson & Johnson is seen in front of an office building in Zug, Switzerland July 20, 2016. Photo: Reuters/Arnd Wiegmann A federal jury in Dallas on Thursday ordered...

DKSH erhält Auftrag von Johnson&Johnson in Hongkong

Zürich (awp) - Der Zürcher DKSH-Konzern erhält einen gewichtigen Auftrag des US-Gesundheitskonzerns Johnson&Johnson. Im Rahmen der Vereinbarung übernimmt DKSH für mehr als 20 Johnson&Johnson-Mark...

New Details Emerge in Johnson & Johnson's Pursuit of Actelion

Back in November, it was confirmed that healthcare conglomerate Johnson & Johnson and Actelion were in discussions, with J&J on the hunt for a new acquisition. Johnson & Johnson reportedly...

Johnson & Johnson tops 4Q profit forecasts

Johnson & Johnson (JNJ) on Tuesday reported fourth-quarter net income of $3.81 billion.

PubMed Articles [323 Associated PubMed Articles listed on BioPortfolio]

Ocular manifestations of Stevens-Johnson syndrome and their management.

Recent advances and outcomes data in the management of Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) demonstrate the need for a universal standard of care for patients admitted wit...

Voices-Perhaps common sense should prevail when it comes to objection.

The recent resignation of James Johnson, Chairman of the British Medical Association (BMA), would not normally be expected to cause many ripples in the world of nursing. But the reason for Dr Johnson'...

Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials.

Lamotrigine is an antiepileptic drug used for the treatment of epilepsy, bipolar disorder and numerous off-label uses. The development of rash significantly affects its use. The most concerning of the...

Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center.

Treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) remains controversial.

9 years of a single referral centre management of Stevens - Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) corresponds to a rare and acute life-threatening mucocutaneous reactions characterized by extensive necrosis and epidermal detachmen...

Clinical Trials [451 Associated Clinical Trials listed on BioPortfolio]

Stevens-Johnson Syndrome Antimicrobial

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Patients diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrolysis were confirmed based on the investigators national diagnostic criteria. Patients who meet all inclusion crit...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

Companies [467 Associated Companies listed on BioPortfolio]

Johnson and Johnson

Johnson & Johnson, employing approximately 119,000 people worldwide, is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnso...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early i...

Johnson & Johnson (China) Investment Co., Ltd.

Johnson & Johnson (China) Investment Co., Ltd. is a foreign investment entity established in China by Johnson & Johnson in 1998. For more information about Johnson & Johnson and its operating unit...


JOHNSON'S® Brand from Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc., has a long tradition of providing pure, mild, gentle and clinically-proven p...


Since 1961 Janssen-Cilag has been a member of the Johnson & Johnson family of companies. Founded in 1886, Johnson & Johnson today is the world's most comprehensive manufacturer of healthcare products ...

More Information about "Johnson and Johnson (France)" on BioPortfolio

We have published hundreds of Johnson and Johnson (France) news stories on BioPortfolio along with dozens of Johnson and Johnson (France) Clinical Trials and PubMed Articles about Johnson and Johnson (France) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Johnson and Johnson (France) Companies in our database. You can also find out about relevant Johnson and Johnson (France) Drugs and Medications on this site too.

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Corporate Database Quicklinks

Searches Linking to this Company Record